|

Efficacy and Safety of Auricular Acupuncture in Depression During the Covid 19 Pandemic

RECRUITINGN/ASponsored by Universidade do Sul de Santa Catarina
Actively Recruiting
PhaseN/A
SponsorUniversidade do Sul de Santa Catarina
Started2023-03-01
Est. completion2025-12-15
Eligibility
Age18 Years – 50 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05855421

Summary

Participants with moderate depressive symptoms measured by PHQ-9 will be randomized to receive auricular acupuncture. The triple blinded procedure will be conducted in 12 sessions (6 weeks). The primary outcome is the response to the treatment 3 months after inclusion.

Eligibility

Age: 18 Years – 50 YearsHealthy volunteers accepted
Inclusion Criteria:

* Age between 18 and 50 years old
* PHQ-9 score between 10 and 19 (moderate depression)
* Availability for sessions

Exclusion Criteria:

Use complementary and integrative practices at the last 3 months; Suicidal risk evaluated by question number 9 in the PHQ-9 Severe depression score in the PHQ-9 Prior use of auricular acupuncture Pregnancy Menopause Tape and metal allergy

Conditions5

AnxietyDepressionDepressive SymptomsInsomniaQuality of Life

Browse More Trials

Depression trialsAnxiety trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.